Ionis initiates Phase 3 clinical program of donidalorsen in patients with hereditary angioedema

Thursday, November 18, 2021 1 min read

Key Takeaway: Ionis initiates Phase 3 clinical program of donidalorsen in patients with hereditary angioedema

Full Press Release Details

Ionis initiates Phase 3 clinical program of donidalorsen in patients with hereditary angioedema.